# Bremelanotide for Treatment of Female Hypoactive Sexual Desire.

> PubMed lists PMID 35076581 in Neurology international as Journal Article, Review, with publication-date metadata of 2022-01-04 (day precision). PeptideScanner associated the retained record with the identity slug bremelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-35076581-bremelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2022-01-28
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-35076581-bremelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-35076581-bremelanotide-v1.json
- Content SHA-256: `9fe5d166535b15977efa797a7c84b5592b648f6d3ea9bc7c80efd417e98d6a14`

## Claims and source pins

### Headline

Bremelanotide for Treatment of Female Hypoactive Sexual Desire. ([`pubmed-observation-pmid-35076581-2022-01-28-306c02855c39`](#source-pubmed-observation-pmid-35076581-2022-01-28-306c02855c39))

### Summary

PubMed lists PMID 35076581 in Neurology international as Journal Article, Review, with publication-date metadata of 2022-01-04 (day precision). PeptideScanner associated the retained record with the identity slug bremelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-35076581-2022-01-28-306c02855c39`](#source-pubmed-observation-pmid-35076581-2022-01-28-306c02855c39))

### Paragraph 1

PubMed lists PMID 35076581 in Neurology international as Journal Article, Review, with publication-date metadata of 2022-01-04 (day precision). PeptideScanner associated the retained record with the identity slug bremelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-35076581-2022-01-28-306c02855c39`](#source-pubmed-observation-pmid-35076581-2022-01-28-306c02855c39))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-35076581-2022-01-28-306c02855c39`](#source-pubmed-observation-pmid-35076581-2022-01-28-306c02855c39))

## Sources

<a id="source-pubmed-observation-pmid-35076581-2022-01-28-306c02855c39"></a>
- **Bremelanotide for Treatment of Female Hypoactive Sexual Desire. · retained source version 1:2022-01-28:current:306c02855c39b8a144562a49bc686e6f30ce22e7aeaf77363a541befd80ba0a0** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/35076581/) (`pubmed-observation-pmid-35076581-2022-01-28-306c02855c39`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Bremelanotide for Treatment of Female Hypoactive Sexual Desire." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-35076581-bremelanotide-v1.json SHA-256: 9fe5d166535b15977efa797a7c84b5592b648f6d3ea9bc7c80efd417e98d6a14.